WS #11712
Dr. Reddy's execs confirm impurity issue in API will halt semaglutide supply to Canada until late October, with potential inventory write-downs and impact on Canadian market. Simply Good Foods (SMPL) reports Q3 EPS of $0.42 beating estimates by $0.07, revenue of $357M beating by $24.38M, and raises FY2026 sales guidance.
Dr. Reddy's Semaglutide Supply Issue
Dr. Reddy's execs confirm impurity issue in API will halt semaglutide supply to Canada until late October, with potential inventory write-downs and impact on Canadian market.
Simply Good Foods (SMPL) reports Q3 EPS of $0.42 beating estimates by $0.07, revenue of $357M beating by $24.38M, and raises FY2026 sales guidance.